Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Silva Markovic-Plese
Differential Reconstitution of T Cell Subsets Following Immunodepleting Treatment With Alemtuzumab (Anti-Cd52 Monoclonal Antibody) in Patients With Relapsing-Remitting Multiple Sclerosis
Journal of Immunology
Allergy
Immunology
Combining Dalfampridine With Multicomponent Exercise and Gait Training in a Person With Multiple Sclerosis
International Journal of MS Care
Neurology
Specialized Nursing
Advanced
Related publications
Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis
Arquivos de Neuro-Psiquiatria
Biological Psychiatry
Neurology
Alemtuzumab: A Review of Efficacy and Risks in the Treatment of Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody
Journal of Immunology
Allergy
Immunology
Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis
Archives of Neurology
Work Participation and Executive Abilities in Patients With Relapsing-Remitting Multiple Sclerosis
PLoS ONE
Multidisciplinary
Acute Effects of Alemtuzumab Infusion in Patients With Active Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Cladribine Tablets, Alemtuzumab and Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis With High Disease Activity in England
Journal of Medical Economics
Health Policy
